|
WO2020198136A1
|
|
Use of rifaximin on circulating aged neutrophils in sickle cell disease
|
|
WO2020190997A1
|
|
Intranasal neuropeptides for use in stress-related impairments
|
|
US2020121641A1
|
|
Antiproliferative DNA Polymerase Inhibitor
|
|
WO2020069077A1
|
|
Generation of post-mitotic migratory cortical interneurons
|
|
US2019338244A1
|
|
Multipotent adult stem cells: characterization and use
|
|
US2019091257A1
|
|
Compositions and methods for restoring endothelial glycocalyx
|
|
US2019183910A1
|
|
Enhancing dna repair and preventing aging and its consequences in reproductive and other cells
|
|
WO2016099453A1
|
|
Use of polymeric material to repair osteochondral defects
|
|
WO2014136118A1
|
|
Treatment of post-traumatic stress disorder with melanocortin receptor antagonist
|
|
AU2013206670A1
|
|
Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor
|
|
WO2013181472A1
|
|
Treatment of stress-related disorders
|
|
WO2012162364A1
|
|
Phenoxybenzamine for pain
|
|
US2011091428A1
|
|
Compositions of adult organ stem cells and uses thereof
|
|
EP2303292A1
|
|
Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium
|
|
AU2008333972A1
|
|
Compositions comprising HDAC inhibitors and methods of their use in restoring stem cell function and preventing heart failure
|
|
AU2008334036A1
|
|
Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
|
|
EP2229177A1
|
|
Methods of isolating non-senescent cardiac stem cells and uses thereof
|
|
US2010173826A1
|
|
Smooth muscle relaxation
|
|
US2006239983A1
|
|
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
US2005244956A1
|
|
Test culture dish
|
